Suraj Singh, MD
Radiation Oncology · Greely, CONPI 1962504704
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $98,247 of the $133,979 with a category attached, or 73.3%. Palette Life Sciences, Inc. accounts for 77.4% of it on its own, with 20 other manufacturers making up the rest. Reporting peaked in 2023 at $106,221 and has fallen 89.8% since, to $10,800 in 2025. Among radiation oncology clinicians in CO with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 181 payments — averaging $740.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Palette Life Sciences, Inc.$104K
- Teleflex LLC$25K
- EMD Serono, Inc.$3K
- GT Medical Technologies, Inc$539
- Siemens Medical Solutions USA, Inc.$265
- AstraZeneca$236
- plus $1K from 15 others
What the payments were for
- Consulting fees$98,24773%
- Speaking & faculty fees$19,11314%
- Travel & lodging$11,2878%
- Food & beverage$5,3334%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Palette Life Sciences, Inc. | 107 | $103,669 |
| Teleflex LLC | 31 | $24,785 |
| EMD Serono, Inc. | 1 | $3,420 |
| GT Medical Technologies, Inc | 2 | $539 |
| Siemens Medical Solutions USA, Inc. | 7 | $265 |
| AstraZeneca | 3 | $236 |
| Merck | 2 | $140 |
| Telix Pharmaceuticals | 2 | $136 |
| Astellas Pharma US Inc | 1 | $125 |
| Sumitomo Pharma America, Inc. | 5 | $120 |
| Boston Scientific | 5 | $116 |
| Novocure Inc. | 3 | $65 |
| E.r. Squibb & Sons, L.L.C. | 3 | $64 |
| Bioprotect Medical, Inc. | 1 | $63 |
| Progenics Pharmaceuticals, Inc. | 2 | $61 |
| Viewray Technologies Inc | 1 | $44 |
| MIM Software Inc. | 1 | $41 |
| Exelixis Inc. | 1 | $26 |
| Myovant Sciences Inc. | 1 | $23 |
| GSK | 1 | $23 |
| Bayer | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$133,979 in reported general payments places this provider in the 95th percentile of 105 radiation oncology providers in Colorado.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| SsdSilver Sulfadiazine | 32 | $1,426 |
| Tamsulosin Hcl | 92 | $1,106 |
| Oxycodone Hcl | 17 | $620 |
| Dexamethasone | 11 | $260 |
| Ondansetron OdtOndansetron | 11 | $184 |
| Ciprofloxacin Hcl | 57 | $154 |
Paid to pharmacies, not to this prescriber.
Other radiation oncology in Greely
- Peter RossiGlenwood Springs$146K
- Meera PatelAurora$112K
- David RabenAurora$61K
- Dustin BootheGreeley$55K
- Kevin ScheweThornton$51K
- Christine FisherAurora$28K
- Thomas PughDenver$15K
- Karyn GoodmanAurora$12K
- Jonathan ClarkDurango$7K
- Patrick RichardBoulder$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.